Pfizer, Merck, J&J to release cancer drug data
Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be …
Merck & Co Inc
Wells Fargo CEO talks up reasons to love the stock — plus, why the market drop
Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market …
Nvidia, Nasdaq record, Australia CPI
Reserve Bank of Australia (RBA) at the central bank’s building in Sydney, Australia on May 2, 2022. Brendon Thorne | Bloomberg | Getty Images Asia-Pacific markets are set for a …
Eli Lilly (LLY) says it can overcome high-quality problem of too much demand
Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly …
Merck (MRK) earnings Q1 2024
The exterior view of the entrance to Merck headquarters in Rahway, New Jersey, on Feb. 5, 2024. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted …
Biotech stocks are ready to break out. They just need one more thing
While debate rages on about when the Federal Reserve might start cutting interest rates, biotech industry analysts are making the case that the argument for stocks in the sector is …
FDA approves Merck drug sotatercept for rare, deadly lung condition
The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for …
First NASH liver disease drug is here, more coming
3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign …
What’s next in Medicare drug price negotiations
Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | …
Pfizer is betting big on cancer drugs after Covid decline
Nurphoto | Nurphoto | Getty Images Pfizer is ready to move on from Covid. Now, the company is betting on cancer drugs to help it regain its footing after a …